These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2454207)

  • 41. Human upper epidermal cytoplasmic antibodies are directed against keratin intermediate filament proteins.
    Hintner H; Steinert PM; Lawley TJ
    J Clin Invest; 1983 Oct; 72(4):1344-51. PubMed ID: 6195191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies: cell surface markers for canine keratinocytes.
    Suter MM; Wilkinson JE; Greenberger L; Smith CA; Lewis RM
    Am J Vet Res; 1987 Sep; 48(9):1367-71. PubMed ID: 2444143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discrimination between immunoaccessory and phagocytic monocytes/macrophages of the skin in paraffin-embedded tissue by the monoclonal antibody Ki-M1P.
    Boehncke WH; Dörhage KW; Harms D; Radzun HJ; Hauschild A; Sterry W
    Br J Dermatol; 1993 Aug; 129(2):124-30. PubMed ID: 7654569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Keratinocyte expression of OKM5 antigen in inflammatory cutaneous disease.
    Barker JN; Markey AC; Allen MH; MacDonald DM
    Br J Dermatol; 1989 May; 120(5):613-8. PubMed ID: 2474314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical reactivity of monoclonal antibodies generated after immunization of mice with cells from a psoriatic lesion.
    Juhlin L; Juhlin C; Scheynius A; Klareskog L
    Acta Derm Venereol; 1989; 69(2):93-100. PubMed ID: 2564242
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal antibodies specific for subsets of epidermal keratins: biochemical and immunocytochemical characterization--applications in pathology and cell culture.
    Knight J; Gusterson B; Jones RR; Landells W; Wilson P
    J Pathol; 1985 Apr; 145(4):341-54. PubMed ID: 2582105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FB1, a monoclonal antibody reacting with a keratin 14 epitope, stains only a small subset of psoriatic basal keratinocytes.
    Parent D; Golstein J; Mairesse N; Bernerd F; Faverly D; Robben H; Ramaekers F; Heenen M
    Cell Prolif; 1994 Mar; 27(3):165-76. PubMed ID: 10465007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1-2B7B: monoclonal antibody reacting to the 120 kDa polypeptide component of human epidermal hemidesmosomes.
    Zhang XM; Horiguchi Y; Ueda M; Yoshiki T; Imamura S
    Arch Dermatol Res; 1991; 283(5):310-6. PubMed ID: 1929554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies in dermatologic research. Studies with a unique cell-surface antigen defined specifically for keratinocytes by a monoclonal antibody.
    Fine JD; Breathnach SM; Fox PA; Neises GR; Stanley JR; Katz SI
    Am J Dermatopathol; 1985 Apr; 7(2):171-9. PubMed ID: 3896008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural quantitation of desmosome and differentiation-related keratinocyte membrane antigen.
    Haftek M; Viac J; Schmitt D; Gaucherand M; Thivolet J
    Arch Dermatol Res; 1986; 278(4):283-92. PubMed ID: 2427039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistologic characterization of epitheloid cells in Crohn's granulomas.
    Miura M; Hiwatashi N; Yamashita K; Kimura M
    J Clin Lab Immunol; 1989 Jan; 28(1):11-4. PubMed ID: 2657071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered keratin expression in benign and malignant skin diseases revealed with monoclonal antibodies.
    Kariniemi AL; Virtanen I
    Am J Dermatopathol; 1989 Jun; 11(3):202-8. PubMed ID: 2471415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding specificity of guinea pig anti-alpha-keratin polypeptide sera on human keratinocytes: comparison of their receptors with those of human epidermal cytoplasmic antibodies.
    Viac J; Schmitt D; Staquet MJ; Thivolet J; Ortonne JP; Bustamante R
    Acta Derm Venereol; 1980; 60(3):189-96. PubMed ID: 6158219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA-DR expression on keratinocytes is a common feature of diseased skin.
    Auböck J; Romani N; Grubauer G; Fritsch P
    Br J Dermatol; 1986 Apr; 114(4):465-72. PubMed ID: 2421756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitation of dendritic cells in normal and abnormal human epidermis using monoclonal antibodies directed against Ia and HTA antigens.
    MacKie RM; Turbitt ML
    J Invest Dermatol; 1983 Sep; 81(3):216-20. PubMed ID: 6577071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Disordered keratinocyte differentiation in epidermal tumors and mycosis fungoides].
    Vavilov AM; Beletskaia LV; Drobyshevakaia EI; Persina IS
    Vestn Dermatol Venerol; 1989; (1):26-9. PubMed ID: 2470216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogold labeling of keratin filaments in normal human epidermal cells with two anti-keratin monoclonal antibodies.
    Haftek M; Staquet MJ; Viac J; Schmitt D; Thivolet J
    J Histochem Cytochem; 1986 May; 34(5):613-8. PubMed ID: 2422248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Skin as a potential organ for ectopic monoclonal antibody production.
    Noël D; Dazard JE; Pelegrin M; Jacquet C; Piechaczyk M
    J Invest Dermatol; 2002 Feb; 118(2):288-94. PubMed ID: 11841546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.